Maximizing rectal dose sparing with hydrogel: A retrospective planning study

Dr Mymoona Alzouebi

“SpaceOAR© hydrogel (SOH) has been incorporated into the radiotherapeutic management of prostate cancer as a result of the proven benefits in reducing rectal toxicity and improving quality of life.
In this study rectal dose sparing of greater than 25% was achieved in most post‐SpaceOAR© Hydrogel treatment plans generated in this planning study.”‍

Read the full study here
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply